MedTrace Logo

Rapid Assessment of Donor Liver Quality

NCT03647059 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-08-27

No results posted yet for this study

Summary

Aims：

1. Conduct multi-center, prospective and open research on liver quality assessment and establish LSCM liver quality assessment system
2. Classification of liver quality grades by LSCM for different pathological conditions (steatosis, fibrosis, hepatocyte necrosis, etc.)
3. Compare the specificity and sensitivity of LSCM evaluation results with the results of liver donor quality evaluation and intraoperative pathological biopsy results.
4. LSCM classifies the quality of donor liver and compares the recovery of liver function on the first day after liver transplantation.
5. LSCM grades the quality of donor liver and compares the long-term prognosis

Conditions

  • Transplant; Failure, Liver

Interventions

DIAGNOSTIC_TEST

LSCM examination

Cut a piece of donor liver and conduct the LSCM examination after staining fluorescein

Sponsors & Collaborators

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Zhong Lin, doctor · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2020-08-15
Completion
2022-08-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03647059 on ClinicalTrials.gov